NEW YORK, Dec. 30 (GenomeWeb News) - Genome Therapeutics and Genesoft Pharmaceuticals today announced that the US Securities and Exchange Commission has approved a registration statement related to their proposed merger that includes a proxy statement that will be mailed to shareholders of both companies.

In addition, the companies said they will each hold a special meeting of their stockholders to vote on the proposed merger and other related matters on Feb. 2, 2004.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.